<?xml version="1.0" encoding="utf-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title><![CDATA[Pharmacy - Newslocker]]></title><link>https://www.newslocker.com/en-us/profession/pharmacy_newslocker/</link><atom:link rel="self" href="https://www.newslocker.com/en-us/profession/pharmacy_newslocker/rss/" /><atom:link rel="hub" href="http://pubsubhubbub.appspot.com" /><description><![CDATA[Find your latest Pharmacy news with just one click. Don't miss out on anything happening in your profession!]]></description><language>en-us</language><copyright>Copyright (C) 2026 newslocker.com</copyright><lastBuildDate>Sun, 06 Sep 2026 02:00:00 +0200</lastBuildDate><item><title><![CDATA[Migraine Flowchart Reduces Opioid Use in the ED]]></title><description><![CDATA[By Karen BlumEnsuring that emergency department (ED) personnel had easy access to the American Headache Society guidelines for managing migraine treatment led to greater guideline compliance, a 50% reduction in the use of opioids, and fewer hospital admissions in a pilot program at Baptist Hospital of Miami.Migraines account for approximately 1.2 million ED visits annually, said Laura Porben Guzman, PharmD, a PGY-2 critical care resident at the hospital. &ldquo;But despite this, less than 25% of]]></description><link>https://www.newslocker.com/en-us/profession/pharmacy_newslocker/migraine-flowchart-reduces-opioid-use-in-the-ed/</link><pubDate>Sun, 06 Sep 2026 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/pharmacy_newslocker/migraine-flowchart-reduces-opioid-use-in-the-ed/</guid></item><item><title><![CDATA[Tough Payor Policies Hamper Ryoncil Access]]></title><description><![CDATA[Originally published by our sister publication Specialty Pharmacy ContinuumBy Gina ShawCassandra Rush, PharmDRemestemcel-L-rknd (Ryoncil, Mesoblast), the first-ever mesenchymal stromal cell therapy, is the only FDA-approved treatment for steroid-refractory acute graft-versus-host disease (SR-aGVHD) in children under 12 years of age. But it comes with some clear financial hurdles.The drug costs approximately $1.94 million for an average 10-dose course, based on its wholesale acquisition cost of $]]></description><link>https://www.newslocker.com/en-us/profession/pharmacy_newslocker/tough-payor-policies-hamper-ryoncil-access/</link><pubDate>Sat, 05 Sep 2026 15:57:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/pharmacy_newslocker/tough-payor-policies-hamper-ryoncil-access/</guid></item><item><title><![CDATA[Stewardship Pharmacists and Physicians Take the Lead on Sustainability]]></title><description><![CDATA[By Gina ShawWhen the shortage of Baxter IV fluids that followed Hurricane Helene in late 2024 strained hospital supplies, antimicrobial stewardship pharmacists at Cleveland Clinic, in Ohio, added a provider-facing alert that prompted clinicians to order oral azithromycin and oral doxycycline at the point of prescribing, rather than waiting for a pharmacist to review each case for an IV-to-oral switch (Antimicrob Steward Healthc Epidemiol 2026;6[1]:e163). The share of azithromycin orders written]]></description><link>https://www.newslocker.com/en-us/profession/pharmacy_newslocker/stewardship-pharmacists-and-physicians-take-the-lead-on-sustainability/</link><pubDate>Sat, 05 Sep 2026 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/pharmacy_newslocker/stewardship-pharmacists-and-physicians-take-the-lead-on-sustainability/</guid></item><item><title><![CDATA[Highly Automated, Highly Distracted? The Human Error Side of Compounding Technology]]></title><description><![CDATA[Originally published by our sister publication Specialty Pharmacy ContinuumBy Gina ShawHighly automated, repetitive compounding tasks in home infusion pharmacies are unintentionally driving technician and pharmacist disengagement, creating patient safety risks that IV workflow management systems (IVWMS), total parenteral nutrition (TPN) compounders, and repeater pumps were designed to eliminate, a panel of sterile compounding experts told attendees at NHIA26, in Denver.&ldquo;We&rsquo;re not tal]]></description><link>https://www.newslocker.com/en-us/profession/pharmacy_newslocker/highly-automated-highly-distracted-the-human-error-side-of-compounding-technology/</link><pubDate>Fri, 04 Sep 2026 15:49:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/pharmacy_newslocker/highly-automated-highly-distracted-the-human-error-side-of-compounding-technology/</guid></item><item><title><![CDATA[HOPA Calls for Formal Residency Leadership Roles]]></title><description><![CDATA[By Gina ShawThe ASHP accreditation standards for pharmacy residency programs formally define three roles: the residency program director (RPD), residency program coordinator (RPC), and preceptor. Beyond those positions, however, the standards offer little guidance on leadership infrastructure.That gap has left many oncology residency programs relying on informal leadership structures, with RPDs carrying growing administrative burdens and preceptors assuming substantial leadership responsibilitie]]></description><link>https://www.newslocker.com/en-us/profession/pharmacy_newslocker/hopa-calls-for-formal-residency-leadership-roles/</link><pubDate>Fri, 04 Sep 2026 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/pharmacy_newslocker/hopa-calls-for-formal-residency-leadership-roles/</guid></item><item><title><![CDATA[5 Questions For … Lisa Dumkow, PharmD]]></title><description><![CDATA[Originally published by our sister publication Infectious Disease Special EditionBy Meaghan Lee Callaghan Photo Courtesy of Lisa DumkowLisa Dumkow, PharmD, BCIDP, FIDP, is an antimicrobial stewardship program (ASP) champion. Dr. Dumkow, a clinical pharmacist in antimicrobial stewardship and the program director of the PGY-2 infectious diseases pharmacy residency at Trinity Health Grand Rapids, in Michigan, and the president of the Society of Infectious Disease Pharmacists (SIDP), sat down with I]]></description><link>https://www.newslocker.com/en-us/profession/pharmacy_newslocker/5-questions-for-lisa-dumkow-pharmd/</link><pubDate>Thu, 03 Sep 2026 15:42:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/pharmacy_newslocker/5-questions-for-lisa-dumkow-pharmd/</guid></item><item><title><![CDATA[Medical Societies Release Flu, COVID, RSV Vaccination Guidelines for Fall Season]]></title><description><![CDATA[Originally published by our sister publication Infectious Disease Special Editionfigure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure img { max-width:100%; height:auto; width:auto; display:block; }figcaption { padding:5px; background:transparent; word-wrap:normal; text-align:center; font-size:10px; line-height:12px; }.figure-wrapper { text-align:center; }Mia B/peopleimages.com - stock.adobe.comBy Karen BlumEveryone older]]></description><link>https://www.newslocker.com/en-us/profession/pharmacy_newslocker/medical-societies-release-flu-covid-rsv-vaccination-guidelines-for-fall-season/</link><pubDate>Thu, 03 Sep 2026 15:40:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/pharmacy_newslocker/medical-societies-release-flu-covid-rsv-vaccination-guidelines-for-fall-season/</guid></item><item><title><![CDATA[Turning Off Wakefulness: Addressing Insomnia in Chronic Pain Patients]]></title><description><![CDATA[Wendy Wright, DNP, discusses her PMAAPP presentation on pharmacologic options for treating insomnia in chronic pain patients.]]></description><link>https://www.newslocker.com/en-us/profession/pharmacy_newslocker/turning-off-wakefulness-addressing-insomnia-in-chronic-pain-patients/</link><pubDate>Thu, 03 Sep 2026 15:11:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/pharmacy_newslocker/turning-off-wakefulness-addressing-insomnia-in-chronic-pain-patients/</guid></item><item><title><![CDATA[From AI to Naloxone: 3 Medication Safety Pearls]]></title><description><![CDATA[By Karen BlumA home-grown artificial intelligence model to review voluntarily reported medication safety events, a program to distribute naloxone kits in the ER, and an effort to reduce sticker clutter on medication packaging were among practice pearls presented at the ASHP 2025 Midyear Clinical Meeting &amp; Exhibition, in Las Vegas.AI Models Can Help Review Med Safety EventsAn in-house developed AI model can help pharmacists and their colleagues better identify true medication safety events, s]]></description><link>https://www.newslocker.com/en-us/profession/pharmacy_newslocker/from-ai-to-naloxone-3-medication-safety-pearls/</link><pubDate>Fri, 28 Aug 2026 14:06:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/pharmacy_newslocker/from-ai-to-naloxone-3-medication-safety-pearls/</guid></item><item><title><![CDATA[Sublingual Cyclobenzaprine Improves Sleep Issues,  Fatigue in Fibromyalgia]]></title><description><![CDATA[Originally published by our sister publication Pain Medicine NewsBy Zoe CunliffeSALT LAKE CITY&mdash;In research presented at the American Academy of Pain Medicine annual PainConnect, investigators found clinically meaningful sleep-related benefits for sublingual cyclobenzaprine hydrochloride (CBP; Tonmya, Tonix), which the FDA approved in late 2025 for the treatmemt of fibromyalgia.The research finds that sublingual CBP not only has a stronger safety profile than prior fibromyalgia therapies, b]]></description><link>https://www.newslocker.com/en-us/profession/pharmacy_newslocker/sublingual-cyclobenzaprine-improves-sleep-issues-fatigue-in-fibromyalgia/</link><pubDate>Thu, 27 Aug 2026 15:05:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/pharmacy_newslocker/sublingual-cyclobenzaprine-improves-sleep-issues-fatigue-in-fibromyalgia/</guid></item><item><title><![CDATA[Safety Gains in Parenteral Nutrition, but Prescribing Gaps Persist]]></title><description><![CDATA[By Marcus A. BanksParenteral nutrition (PN) practices have become safer in some respects, but inconsistent prescribing, limited oversight, and confusion about beyond-use dating continue to put patients at risk, according to an American Society for Parenteral and Enteral Nutrition (ASPEN) survey.The survey sought feedback from 1,160 clinicians involved in PN care, including pharmacists, dietitians, nurses, and physicians. Approximately 80% worked with adults, one-third with pediatric patients, an]]></description><link>https://www.newslocker.com/en-us/profession/pharmacy_newslocker/safety-gains-in-parenteral-nutrition-but-prescribing-gaps-persist/</link><pubDate>Thu, 27 Aug 2026 12:11:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/pharmacy_newslocker/safety-gains-in-parenteral-nutrition-but-prescribing-gaps-persist/</guid></item><item><title><![CDATA[FDA Approves Daraxonrasib for Metastatic Pancreatic Cancer]]></title><description><![CDATA[Originally published by our sister publication Clinical Oncology NewsBy CONC StaffThe FDA has approved daraxonrasib (Rasonque, Revolution Medicines) for the treatment of adults with metastatic pancreatic cancer who have received at least one prior systemic therapy or who are not candidates for multiagent systemic therapy.The once-daily pill is a RAS(ON) multi-selective, tri-complex inhibitor that roughly doubled overall survival (OS) in patients with previously treated metastatic pancreatic duct]]></description><link>https://www.newslocker.com/en-us/profession/pharmacy_newslocker/fda-approves-daraxonrasib-for-metastatic-pancreatic-cancer/</link><pubDate>Wed, 26 Aug 2026 19:36:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/pharmacy_newslocker/fda-approves-daraxonrasib-for-metastatic-pancreatic-cancer/</guid></item><item><title><![CDATA[It’s Time for a More Holistic Approach to Affordability]]></title><description><![CDATA[Originally published by our sister publication Specialty Pharmacy ContinuumBy Gina ShawCancer treatments have become so effective that many patients now fear financial ruin more than dying from their disease. The concern is well founded: Such patients are 2.5 times more likely to declare bankruptcy than healthy individuals, according to Lyndsey Griffin, LCSW-C, the manager of cancer program accreditation at University of Maryland Baltimore Washington Medical Center. The 2026 insurance landscape]]></description><link>https://www.newslocker.com/en-us/profession/pharmacy_newslocker/its-time-for-a-more-holistic-approach-to-affordability/</link><pubDate>Wed, 26 Aug 2026 19:29:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/pharmacy_newslocker/its-time-for-a-more-holistic-approach-to-affordability/</guid></item><item><title><![CDATA[Safety Groups Sound Alarm After FDA Compounding Panel Backs 6 of 7 Peptides]]></title><description><![CDATA[Originally published by our sister publication Specialty Pharmacy Continuumfigure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure img { max-width:100%; height:auto; width:auto; display:block; }figcaption { padding:5px; background:transparent; word-wrap:normal; text-align:center; font-size:10px; line-height:12px; }.figure-wrapper { text-align:center; }Atrom, Piya W. - Stock.adobe.com.By Gina ShawThe FDA Pharmacy Compounding]]></description><link>https://www.newslocker.com/en-us/profession/pharmacy_newslocker/safety-groups-sound-alarm-after-fda-compounding-panel-backs-6-of-7-peptides/</link><pubDate>Wed, 26 Aug 2026 11:49:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/pharmacy_newslocker/safety-groups-sound-alarm-after-fda-compounding-panel-backs-6-of-7-peptides/</guid></item><item><title><![CDATA[2 Measles-Associated Deaths in Pennsylvania]]></title><description><![CDATA[Originally published by our sister publication Infectious Disease Special EditionBy Meaghan Lee CallaghanTwo people have died possibly due to complications of measles infections in Pennsylvania, which is currently experiencing a growing outbreak.figure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure img { max-width:100%; height:auto; width:auto; display:block; }figcaption { padding:5px; background:transparent; word-wrap:nor]]></description><link>https://www.newslocker.com/en-us/profession/pharmacy_newslocker/2-measles-associated-deaths-in-pennsylvania/</link><pubDate>Tue, 25 Aug 2026 18:37:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/pharmacy_newslocker/2-measles-associated-deaths-in-pennsylvania/</guid></item><item><title><![CDATA[An Oklahoma Health System’s Road  To Dual-Specialty Accreditation]]></title><description><![CDATA[Originally published by our sister publication Specialty Pharmacy ContinuumBy Gina Shaw Christopher Wilson, PharmDFor many patients with cancer and other complex conditions across southwest Oklahoma, filling a specialty prescription has often meant waiting for a package to arrive by mail. That changed when the specialty pharmacy at Memorial Health System of Southwest Oklahoma, in Lawton, earned accreditation from both URAC and the Accreditation Commission for Health Care (ACHC).Memorial Health&r]]></description><link>https://www.newslocker.com/en-us/profession/pharmacy_newslocker/an-oklahoma-health-systems-road-to-dual-specialty-accreditation/</link><pubDate>Mon, 24 Aug 2026 14:57:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/pharmacy_newslocker/an-oklahoma-health-systems-road-to-dual-specialty-accreditation/</guid></item><item><title><![CDATA[How Hospital Pharmacies Can Access Restrictive Specialty Networks]]></title><description><![CDATA[Originally published by our sister publication Specialty Pharmacy ContinuumBy Gina ShawAs payors and pharmacy benefit managers (PBMs) narrow specialty pharmacy networks, health-system pharmacies face increasing exclusion from dispensing high-cost therapies to their own patients. For many organizations, accessing these restrictive networks has become both a strategic imperative and an operational challenge.Signature Healthcare, a regional health system in southern Massachusetts, addressed this ch]]></description><link>https://www.newslocker.com/en-us/profession/pharmacy_newslocker/how-hospital-pharmacies-can-access-restrictive-specialty-networks/</link><pubDate>Mon, 24 Aug 2026 14:44:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/pharmacy_newslocker/how-hospital-pharmacies-can-access-restrictive-specialty-networks/</guid></item><item><title><![CDATA[Student Pharmacy Phone Calls Boost Cancer Pain Management]]></title><description><![CDATA[Originally published by our sister publication Specialty Pharmacy ContinuumBy Francesca KritzNearly half of cancer patients experience pain, yet many struggle to manage it because of limited education, poor communication with providers, and concerns about opioid use. But a new study suggests that a simple educational phone call from supervised pharmacy students may help improve pain control.&ldquo;More efforts are needed to address this common, yet debilitating symptom,&rdquo; said lead author J]]></description><link>https://www.newslocker.com/en-us/profession/pharmacy_newslocker/student-pharmacy-phone-calls-boost-cancer-pain-management/</link><pubDate>Mon, 24 Aug 2026 14:32:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/pharmacy_newslocker/student-pharmacy-phone-calls-boost-cancer-pain-management/</guid></item><item><title><![CDATA[New Consensus Recs For Tardive Dyskinesia Focus on Long-Term Rx]]></title><description><![CDATA[Originally published by our sister publication Specialty Pharmacy ContinuumBy Gina ShawFor the first time, clinicians caring for older adults in long-term care settings have expert-developed guidance on how to screen, diagnose, and treat tardive dyskinesia (TD).&ldquo;These guidelines are bringing attention to a population that has historically been underrecognized,&rdquo; Swati Pradeep, DO, an assistant professor of neurology at McGovern Medical School at UTHealth Houston, told Specialty Pharma]]></description><link>https://www.newslocker.com/en-us/profession/pharmacy_newslocker/new-consensus-recs-for-tardive-dyskinesia-focus-on-long-term-rx/</link><pubDate>Mon, 24 Aug 2026 13:29:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/pharmacy_newslocker/new-consensus-recs-for-tardive-dyskinesia-focus-on-long-term-rx/</guid></item><item><title><![CDATA[New Phase 3 Data Show BEM/RZR Noninferior to Epclusa for Hep C]]></title><description><![CDATA[Originally published by our sister publication Infectious Disease Special EditionBy Meaghan Lee CallaghanBemnifosbuvir/ruzasvir (BEM/RZR; Atea) has met its primary and secondary end points in the phase 3 C-BEYOND trial in patients with hepatitis C, showing noninferiority to standard-of-care sofosbuvir/velpatasvir (SOF/VEL; Epclusa, Gilead), according to the drugmaker.figure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure im]]></description><link>https://www.newslocker.com/en-us/profession/pharmacy_newslocker/new-phase-3-data-show-bemrzr-noninferior-to-epclusa-for-hep-c/</link><pubDate>Thu, 20 Aug 2026 11:32:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/pharmacy_newslocker/new-phase-3-data-show-bemrzr-noninferior-to-epclusa-for-hep-c/</guid></item></channel></rss>